Pronton radiation+sutent possible radiosensitizer

[D.ap]

Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report


"Conclusions.

Our study is the first to show that sunitinib has beneficial activity in chondrosarcoma and may be safely combined with proton beam radiation therapy. Randomized phase II or III clinical trials are needed to assess the role of sunitinib in this disease and as a radiosensitizer."

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277477/